Comparative efficacy of mind-body exercises for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis.

Clin RehabilApr 29, 2026 (epub)
Clinical ResearchPulmonology

Qian Gao, Peijun Li, Xiaoyu Han et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and network meta-analysis evaluated the effectiveness of various mind-body exercises in treating chronic obstructive pulmonary disease (COPD) among 3179 participants. The study found that Pilates combined with pulmonary rehabilitation significantly improved exercise capacity and pulmonary function, while Tai Chi was most effective in reducing dyspnea and enhancing health-related quality of life.

Key findings

  • Pilates plus pulmonary rehabilitation showed the largest improvement in exercise capacity.
  • Tai Chi, alone or with pulmonary rehabilitation, was superior in reducing dyspnea.
  • Tai Chi plus pulmonary rehabilitation and Qigong provided the greatest benefits for health-related quality of life.

Why it matters

Understanding the comparative effectiveness of mind-body exercises can help clinicians tailor rehabilitation programs for COPD patients, potentially improving both physical and psychological outcomes.

Source

PubMed · PMID 42053497

Published in Clin Rehabil. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pulmonology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.